Zoqick IT 20mg/150mg Capsule SR

Introduction

Zoqick IT is a prescription medication that contains the active ingredients Rabeprazole and Itopride. It is available in capsule form and is used for the treatment of certain gastrointestinal conditions.

Uses

Zoqick IT is primarily prescribed for the following conditions:

• Gastroesophageal reflux disease (GERD): It helps reduce the production of stomach acid and provides relief from symptoms such as heartburn, acid reflux, and regurgitation.
• Dyspepsia: It helps improve digestion and provides relief from symptoms such as bloating, abdominal discomfort, and early satiety.

Dosage and Administration

• The dosage of Zoqick IT may vary depending on the individual’s condition and response to treatment. Follow the instructions provided by your healthcare provider.
• The capsules should be swallowed whole with a glass of water, preferably before meals.
• Do not crush or chew the capsules, as it may affect the way the medication is released in the body.

Mechanism of Action

• Rabeprazole, one of the active ingredients in Zoqick IT, belongs to a class of medications known as proton pump inhibitors (PPIs). It works by reducing the production of stomach acid, thereby helping to alleviate symptoms associated with acid-related conditions.
• Itopride, the other active ingredient, is a prokinetic agent that enhances gastrointestinal motility and helps improve the movement of food through the digestive system.

Side Effects

Common side effects may include:

• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Flatulence

Serious side effects are rare but may include:

• Allergic reactions
• Severe abdominal pain
• Difficulty breathing
• Chest pain

If you experience any severe or persistent side effects, seek medical attention immediately.

Drug Interactions

Zoqick IT may interact with certain medications, including:

• Anticoagulants (blood thinners) such as warfarin
• Antiplatelet drugs such as clopidogrel
• Antifungal medications such as ketoconazole
• Antidepressants such as fluoxetine
• Antacids containing aluminum or magnesium

Precautions

• Before taking Zoqick IT, inform your healthcare provider about any allergies or medical conditions you have.
• disclose all medications you are currently taking to your healthcare provider to avoid potential interactions.
• Zoqick IT may not be suitable for individuals with certain medical conditions, such as liver or kidney problems. Your healthcare provider will assess your condition and determine if this medication is appropriate for you.
• Pregnant or breastfeeding individuals should consult their healthcare provider before taking Zoqick IT.

Storage

• Zoqick IT should be stored at room temperature, away from moisture and heat.
• Keep the medication out of reach of children and pets.
• Do not use the medication after the expiration date printed on the packaging.

Patient Tips

• Take Zoqick IT exactly as prescribed by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not exceed the recommended dosage without consulting your healthcare provider.
• If you experience any unusual or persistent symptoms while taking Zoqick IT, contact your healthcare provider.
• Follow a healthy lifestyle, including a balanced diet and regular exercise, to support the effectiveness of the medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Rabeprazole: medicine to lower stomach acid (NHS UK) [Accessed 30 Jun. 2024] (online) Available at:
• PARIET 10mg (Health Professionals SmPC) Available at:
• Itopride (International database) (Drugs.com) [Accessed 1 Jun. 2024] (online) Available at:
• rabeprazole sodium (RX) [Accessed 26 Jun. 2024] (online) Available at:
• Rabeprazole (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
• Dzierżanowski T, Kozlowski M. Itopride increases the effectiveness of the management of opioid-induced constipation in palliative care patients: an observational non-interventional study. Arch Med Sci. 2019 Jul 18;18(5):1271-1278. doi: 10.5114/aoms.2019.85943. eCollection 2022. [Accessed 13 Jun. 2024] Available at: